Autologous Splenocyte Reinfusion Improves Antibody-Mediated Immune Response to the 23-Valent Pneumococcal Polysaccharide-Based Vaccine in Splenectomized Mice
Common clinical options, currently, for necessary splenectomy are vaccinations and antibiotic prophylaxis. However, despite these two adjuncts, there still occur numerous cases of overwhelming post-splenectomy infection. To examine whether reperfusion of critical splenic lymphocytes could boost immu...
Main Authors: | Shengwen Calvin Li, Mustafa H. Kabeer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/5/704 |
Similar Items
-
Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?
by: Şerife Solmaz Medeni, et al.
Published: (2018-11-01) -
Chyme reinfusion therapy using new technology
by: Gil Hardy
Published: (2023-09-01) -
Environmental factors which can affect the burden of pneumococcal disease and the immune response to pneumococcal vaccines: the need for more precisely delineated vaccine recommendations
by: Seong-Beom Park, et al.
Published: (2019-06-01) -
Extracorporal modified ascitic fluid reinfusion in treatment of resistant ascites in liver cirrhosis
by: I. E. Onnintsev, et al.
Published: (2017-06-01) -
Antiviral Resistance of Splenocytes in Aged Mice
by: Ewa Zaczyńska, et al.
Published: (2017-03-01)